Pyronaridine
 | |
| Clinical data | |
|---|---|
| Other names | Pyronaridine tetraphosphate |
| Routes of administration | Oral, intramuscular injection, intravenous therapy |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
JSmol) | |
| |
| |
  (what is this?) (verify) | |
Pyronaridine is an
antimalarial drug.[1] It was first made in 1970 and has been in clinical use in China since the 1980s.[2]
In a small (n=88) malaria study in Camaroon, pyronaridine had a 100% cure rate, compared with 60% for chloroquine.[3]
It is one of the components of the
pyronaridine/artesunate (Pyramax).[4]
It has also been studied as a potential anticancer drug,[5] and treatment for Ebola. The combination of pyronaridine and artesunate has been evaluated to have a synergistic effect of stronger antiviral effect and less toxicity.[6] The combination of pyronaridine and artesunate is being studied as a possible treatment for moderate to severe SARS-COV-2.[7]